Liberty All-Star Growth Fund Incの収益はセグメントまたは地域別にどのように分けられていますか?
Serina Therapeutics Inc の最大収益セグメントは Grant Revenues で、最新の利益発表における収益は 77,000 です。地域別に見ると、United States が Serina Therapeutics Inc の主要市場であり、収益は 90,000 です。
Liberty All-Star Growth Fund Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Serina Therapeutics Incの純損失は$0です。
Liberty All-Star Growth Fund Incに負債はありますか?
いいえ、Serina Therapeutics Incの負債は0です。
Liberty All-Star Growth Fund Incの発行済株式数は何株ですか?
Serina Therapeutics Incの総発行済株式数は0株です。
主要データ
前終値
$5.31
始値
$5.33
当日レンジ
$5.28 - $5.34
52週レンジ
$4.55 - $5.69
取引高
329.5K
平均取引高
289.5K
配当利回り
--
1株当たり利益(TTM)
--
時価総額
$333.7M
ASGとは何ですか?
Liberty All-Star Growth Fund Inc is a US-based company operating in industry. The company is headquartered in Denver, Colorado. Liberty All-Star Growth Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to seek long-term capital appreciation. The Fund seeks to achieve its investment objective through investing at least 65% of its net assets in a diversified portfolio of equity securities of companies of any market capitalization. The Fund will remain substantially fully invested in equity securities, up to 35% of the value of the Fund's total assets may generally be invested in the United States Government Securities, repurchase agreements with respect to the United States Government Securities, and, to an extent not greater than 10% of the market value of the Fund's total assets, money market mutual funds that invest primarily in the United States Government Securities. The Fund may invest in the securities of other investment companies. The Fund's investment advisor is ALPS Advisors, Inc.